Wednesday, January 10, 2018

Challenging conditions in the U.S. generic drug market have hit drugmaker Teva Pharmaceutical Industries Ltd. particularly hard.


from MarketWatch.com - Top Stories http://ift.tt/2CW3tLt

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner